Capreomycin is an antibiotic used mainly for the treatment of multidrug-resistant tuberculosis. It inhibits bacterial protein synthesis to fight infections. Capreomycin is an injectable broad spectrum antibiotic used in the therapy of drug resistant tuberculosis as a second line agent, always in combination with other antituberculosis drugs. Capreomycin has not been linked to cases of clinically apparent liver disease. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Capostatin, Capreomicina and Capastat. Its PubChem CID is 3000502.
Capreomycin
| CAS No | 11003-38-6 |
|---|---|
| Molecular Formula | C50H88N28O15 |
| Molecular Weight | 1321.4 g/mol |
| Synonyms | (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Capreomycin is an antibiotic used mainly for the treatment of multidrug-resistant tuberculosis. It inhibits bacterial protein synthesis to fight infections.
The listed CAS number is 11003-38-6.
The listed molecular formula is C50H88N28O15.
The listed molecular weight is 1321.4 g/mol.
The source lists Capostatin, Capreomicina and Capastat.
Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars.